Emodin regulates glucose utilization by activating amp-activated protein kinase

Journal of Biological Chemistry

Volumn 288, Issue 8, 2013, Pages 5732-5742

  Song, Parkyong ^a   Kim, Jong Hyun ^a   Ghim, Jaewang ^a   Yoon, Jong Hyuk ^b   Lee, Areum ^a   Kwon, Yonghoon ^a   Hyun, Hyunjung ^a   Moon, Hyo Youl ^c   Choi, Hueng Sik ^d   Berggren, Per Olof ^a,e   Suh, Pann Ghill ^c   Ryu, Sung Ho ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b NovaCell Technology Inc   (South Korea)

^c Ulsan National Institute of Science and Technology   (South Korea)

^d Chonnam National University   (South Korea)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ACTIVATION; INSULIN; MUSCLE;

AMP-ACTIVATED PROTEIN KINASE; BLOOD GLUCOSE LEVEL; GLUCOSE TOLERANCE; GLUCOSE UPTAKE; IN-VIVO; INSULIN SENSITIVITY; POTENTIAL VALUES; SKELETAL MUSCLE;

GLUCOSE;

EMODIN; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; METFORMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

EID: 84874314479     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.441477     Document Type: Article

References (53)

1. Hardie, D. G. (2004) The AMP-activated protein kinase pathway-new players upstream and downstream. J. Cell Sci. 117, 5479-5487
2. Kahn, B. B., Alquier, T., Carling, D., and Hardie, D. G. (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15-25
3. Hardie, D. G. (2007) AMP-activated/SNF1 protein kinases. Conserved guardians of cellular energy. Nat. Rev. Mol. Cell Biol. 8, 774-785
4. Koistinen, H. A., Galuska, D., Chibalin, A. V., Yang, J., Zierath, J. R., Holman, G. D., and Wallberg-Henriksson, H. (2003) 5-Amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 52, 1066-1072
5. Musi, N., Hayashi, T., Fujii, N., Hirshman, M. F., Witters, L. A., and Goodyear, L. J. (2001) AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 280, E677-E684
6. Lochhead, P. A., Salt, I. P., Walker, K. S., Hardie, D. G., and Sutherland, C. (2000) 5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49, 896-903
7. Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S., Moller, D. E., Thorell, A., and Goodyear, L. J. (2002) Metformin increases AMPactivated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51, 2074-2081
8. Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., Roden, M., Gnaiger, E., Nohl, H., Waldhäusl, W., and Fürnsinn, C. (2004) Thiazolidinediones, like metformin, inhibit respiratory complex I. A common mechanism contributing to their antidiabetic actions? Diabetes 53, 1052-1059
9. Hawley, S. A., Ross, F. A., Chevtzoff, C., Green, K. A., Evans, A., Fogarty, S., Towler, M. C., Brown, L. J., Ogunbayo, O. A., Evans, A. M., and Hardie, D. G. (2010) Use of cells expressing-subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab. 11, 554-565
10. Lambert, A. J., and Brand, M. D. (2004) Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH: ubiquinone oxidoreductase (complex I). J. Biol. Chem. 279, 39414-39420
11. DeFronzo, R. A., and Goodman, A. M. (1995) Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N. Engl. J. Med. 333, 541-549
12. Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., and Gerich, J. E. (1995) Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 333, 550-554
13. Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V., Chandramouli, V., Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., and Shulman, G. I. (2000) Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49, 2063-2069
14. Yang, Y., Shang, W., Zhou, L., Jiang, B., Jin, H., and Chen, M. (2007) Emodin with PPAR-ligand-binding activity promotes adipocyte differentiation and increases glucose uptake in 3T3-Ll cells. Biochem. Biophys. Res. Commun. 353, 225-230
15. Wang, C. H., Gao, Z. Q., Ye, B., Cai, J. T., Xie, C. G., Qian, K. D., and Du, Q. (2007) Effect of emodin on pancreatic fibrosis in rats. World J. Gastroenterol. 13, 378-382
16. Imanishi, Y., Maeda, N., Otogawa, K., Seki, S., Matsui, H., Kawada, N., and Arakawa, T. (2004) Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats. J. Hepatol. 41, 242-250
17. Yea, K., Kim, J., Lim, S., Park, H. S., Park, K. S., Suh, P. G., and Ryu, S. H. (2008) Lysophosphatidic acid regulates blood glucose by stimulating myotube and adipocyte glucose uptake. J. Mol. Med. 86, 211-220
18. Mu, J., Brozinick, J. T., Jr., Valladares, O., Bucan, M., and Birnbaum, M. J. (2001) A role for AMP-activated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell 7, 1085-1094
19. Zong, H., Ren, J. M., Young, L. H., Pypaert, M., Mu, J., Birnbaum, M. J., and Shulman, G. I. (2002) AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. U.S.A. 99, 15983-15987
20. Kandror, K. V. (2003) A long search for Glut4 activation. Sci. STKE 2003, PE5
21. Somwar, R., Perreault, M., Kapur, S., Taha, C., Sweeney, G., Ramlal, T., Kim, D. Y., Keen, J., Côte, C. H., Klip, A., and Marette, A. (2000) Activation of p38 mitogen-activated protein kinase-and-by insulin and contraction in rat skeletal muscle. Potential role in the stimulation of glucose transport. Diabetes 49, 1794-1800
22. Yi, J., Yang, J., He, R., Gao, F., Sang, H., Tang, X., and Ye, R. D. (2004) Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Res. 64, 108-116
23. Choi, S. L., Kim, S. J., Lee, K. T., Kim, J., Mu, J., Birnbaum, M. J., Soo Kim, S., and Ha, J. (2001) The regulation of AMP-activated protein kinase by H2O2. Biochem. Biophys. Res. Commun. 287, 92-97
24. Park, I. J., Lee, Y. K., Hwang, J. T., Kwon, D. Y., Ha, J., and Park, O. J. (2009) Green tea catechin controls apoptosis in colon cancer cells by attenuation of H2O2-stimulated COX-2 expression via the AMPK signaling pathway at low-dose H2O2. Ann. N.Y. Acad. Sci. 1171, 538-544
25. Zmijewski, J. W., Banerjee, S., Bae, H., Friggeri, A., Lazarowski, E. R., and Abraham, E. (2010) Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J. Biol. Chem. 285, 33154-33164
26. Hattori, A., Mawatari, K., Tsuzuki, S., Yoshioka, E., Toda, S., Yoshida, M., Yasui, S., Furukawa, H., Morishima, M., Ono, K., Ohnishi, T., Nakano, M., Harada, N., Takahashi, A., and Nakaya, Y. (2010) β-Adrenergic-AMPK pathway phosphorylates acetyl-CoA carboxylase in a high-epinephrine rat model, SPORTS. Obesity 18, 48-54
27. Lumeng, C. N., and Saltiel, A. R. (2011) Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121, 2111-2117
28. Cha, T. L., Qiu, L., Chen, C. T., Wen, Y., and Hung, M. C. (2005) Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Res. 65, 2287-2295
29. Su, Y. T., Chang, H. L., Shyue, S. K., and Hsu, S. L. (2005) Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem. Pharmacol. 70, 229-241
30. Kumar, A., Dhawan, S., and Aggarwal, B. B. (1998) Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-B activation, I-B degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene 17, 913-918
31. Liu, Y. X., Shen, N. Y., Liu, C., and Lv, Y. (2009) Immunosuppressive effects of emodin. An in vivo and in vitro study. Transplant. Proc. 41, 1837-1839
32. Jahnke, G. D., Price, C. J., Marr, M. C., Myers, C. B., and George, J. D. (2004) Developmental toxicity evaluation of emodin in rats and mice. Birth Defects Res. B. Dev. Reprod. Toxicol. 71, 89-101
33. Oshida, K., Hirakata, M., Maeda, A., Miyoshi, T., and Miyamoto, Y. (2011) Toxicological effect of emodin in mouse testicular gene expression profile. J. Appl. Toxicol. 31, 790-800
34. Owen, M. R., Doran, E., and Halestrap, A. P. (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348, 607-614
35. Lenaz, G., Fato, R., Genova, M. L., Bergamini, C., Bianchi, C., and Biondi, A. (2006) Mitochondrial complex I. Structural and functional aspects. Biochim. Biophys. Acta 1757, 1406-1420
36. Feng, Y., Huang, S. L., Dou, W., Zhang, S., Chen, J. H., Shen, Y., Shen, J. H., and Leng, Y. (2010) Emodin, a natural product, selectively inhibits 11-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice. Br. J. Pharmacol. 161, 113-126
37. Sandeep, T. C., Andrew, R., Homer, N. Z., Andrews, R. C., Smith, K., and Walker, B. R. (2005) Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 54, 872-879
38. Zurlo, F., Larson, K., Bogardus, C., and Ravussin, E. (1990) Skeletal muscle metabolism is a major determinant of resting energy expenditure. J. Clin. Invest. 86, 1423-1427
39. Lee, Y. S., Kim, W. S., Kim, K. H., Yoon, M. J., Cho, H. J., Shen, Y., Ye, J. M., Lee, C. H., Oh, W. K., Kim, C. T., Hohnen-Behrens, C., Gosby, A., Kraegen, E. W., James, D. E., and Kim, J. B. (2006) Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55, 2256-2264
40. Watt, M. J., Dzamko, N., Thomas, W. G., Rose-John, S., Ernst, M., Carling, D., Kemp, B. E., Febbraio, M. A., and Steinberg, G. R. (2006) CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat. Med. 12, 541-548
41. Tzeng, T. F., Lu, H. J., Liou, S. S., Chang, C. J., and Liu, I. M. (2012) Emodin, a naturally occurring anthraquinone derivative, ameliorates dyslipidemia by activating AMP-activated protein kinase in high-fat-diet-fed rats. Evid. Based Complement. Alternat. Med. 2012, 781812
42. Tzeng, T. F., Lu, H. J., Liou, S. S., Chang, C. J., and Liu, I. M. (2012) Emodin protects against high-fat diet-induced obesity via regulation of AMP-activated protein kinase pathways in white adipose tissue. Planta Med. 78, 943-950
43. Katz, A. (2007) Modulation of glucose transport in skeletal muscle by reactive oxygen species. J. Appl. Physiol. 102, 1671-1676
44. Loh, K., Deng, H., Fukushima, A., Cai, X., Boivin, B., Galic, S., Bruce, C., Shields, B. J., Skiba, B., Ooms, L. M., Stepto, N., Wu, B., Mitchell, C. A., Tonks, N. K., Watt, M. J., Febbraio, M. A., Crack, P. J., Andrikopoulos, S., and Tiganis, T. (2009) Reactive oxygen species enhance insulin sensitivity. Cell Metab. 10, 260-272
45. Leslie, N. R., Bennett, D., Lindsay, Y. E., Stewart, H., Gray, A., and Downes, C. P. (2003) Redox regulation of PI 3-kinase signaling via inactivation of PTEN. EMBO J. 22, 5501-5510
46. An, Z., Wang, H., Song, P., Zhang, M., Geng, X., and Zou, M. H. (2007) Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes. A role for oxidant stress. J. Biol. Chem. 282, 26793-26801
47. Choi, H. C., Song, P., Xie, Z., Wu, Y., Xu, J., Zhang, M., Dong, Y., Wang, S., Lau, K., and Zou, M. H. (2008) Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo. J. Biol. Chem. 283, 20186-20197
48. Merry, T. L., and McConell, G. K. (2009) Skeletal muscle glucose uptake during exercise. A focus on reactive oxygen species and nitric oxide signaling. IUBMB Life 61, 479-484
49. Sandström, M. E., Zhang, S. J., Bruton, J., Silva, J. P., Reid, M. B., Westerblad, H., and Katz, A. (2006) Role of reactive oxygen species in contraction-mediated glucose transport in mouse skeletal muscle. J. Physiol. 575, 251-262
50. Collins, Q. F., Liu, H. Y., Pi, J., Liu, Z., Quon, M. J., and Cao, W. (2007) Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5-AMP-activated protein kinase. J. Biol. Chem. 282, 30143-30149
51. Fujita, Y., Hosokawa, M., Fujimoto, S., Mukai, E., Abudukadier, A., Obara, A., Ogura, M., Nakamura, Y., Toyoda, K., Nagashima, K., Seino, Y., and Inagaki, N. (2010) Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice. Diabetologia 53, 1472-1481
52. Ross, R. M., Wadley, G. D., Clark, M. G., Rattigan, S., and McConell, G. K. (2007) Local nitric oxide synthase inhibition reduces skeletal muscle glucose uptake but not capillary blood flow during in situ muscle contraction in rats. Diabetes 56, 2885-2892
53. Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S. H., Bardeesy, N., Depinho, R. A., Montminy, M., and Cantley, L. C. (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-1646